137 related articles for article (PubMed ID: 32622850)
1. Phosphodiesterase-5 inhibitors ameliorate structural kidney damage in a rat model of contrast-induced nephropathy.
Iordache AM; Buga AM; Albulescu D; Vasile RC; Mitrut R; Georgiadis G; Zisis IE; Mamoulakis C; Tsatsakis A; Docea AO; Calina D
Food Chem Toxicol; 2020 Sep; 143():111535. PubMed ID: 32622850
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil and tadalafil reduce the risk of contrast-induced nephropathy by modulating the oxidant/antioxidant balance in a murine model.
Iordache AM; Docea AO; Buga AM; Zlatian O; Ciurea ME; Rogoveanu OC; Burada F; Sosoi S; Mitrut R; Mamoulakis C; Albulescu D; Vasile RC; Tsatsakis A; Calina D
Food Chem Toxicol; 2020 Jan; 135():111038. PubMed ID: 31825855
[TBL] [Abstract][Full Text] [Related]
3. Serum and Tissue HIF-2 Alpha Expression in CIN, N-Acetyl Cysteine, and Sildenafil-Treated Rat Models: An Experimental Study.
Altintop I; Tatli M; Karakukcu C; Soyer Sarica Z; Hanım Yay A; Balcioglu E; Ozturk A
Medicina (Kaunas); 2018 Jul; 54(4):. PubMed ID: 30344285
[No Abstract] [Full Text] [Related]
4. Impact of pretreatment with carnitine and tadalafil on contrast-induced nephropathy in CKD patients.
Armaly Z; Artol S; Jabbour AR; Saffouri A; Habashi N; Abd Elkadir A; Ghattas N; Farah R; Kinaneh S; Nseir W
Ren Fail; 2019 Nov; 41(1):976-986. PubMed ID: 31797710
[No Abstract] [Full Text] [Related]
5. The protective effect of single dose tadalafil in contrast-induced nephropathy: an experimental study.
Özbek K; Ceyhan K; Koç F; Söğüt E; Altunkaş F; Karayakalı M; Çelik A; Kadı H; Köseoğlu RD; Önalan O
Anatol J Cardiol; 2015 Apr; 15(4):306-10. PubMed ID: 25880289
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil obviates ischemia-reperfusion injury-induced acute kidney injury through peroxisome proliferator-activated receptor γ agonism in rats.
Mohey V; Singh M; Puri N; Kaur T; Pathak D; Singh AP
J Surg Res; 2016 Mar; 201(1):69-75. PubMed ID: 26850186
[TBL] [Abstract][Full Text] [Related]
7. Sildenafil citrate for prophylaxis of nephropathy in an animal model of contrast-induced acute kidney injury.
Lauver DA; Carey EG; Bergin IL; Lucchesi BR; Gurm HS
PLoS One; 2014; 9(11):e113598. PubMed ID: 25426714
[TBL] [Abstract][Full Text] [Related]
8. Positive effect of tadalafil, a phosphodiesterase-5 inhibitor, on fracture healing in rat femur.
Toğral G; Arıkan M; Korkusuz P; Hesar RH; Ekşioğlu MF
Eklem Hastalik Cerrahisi; 2015; 26(3):137-44. PubMed ID: 26514217
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase 5 inhibitors attenuate renal tubular apoptosis after partial unilateral ureteral obstruction: an experimental study.
Akgül T; Huri E; Yagmurdur H; Ayyıldız A; Ustün H; Germiyanoğlu C
Kaohsiung J Med Sci; 2011 Jan; 27(1):15-9. PubMed ID: 21329887
[TBL] [Abstract][Full Text] [Related]
10. Renal Protective Effect of Probucol in Rats with Contrast-Induced Nephropathy and its Underlying Mechanism.
Wang N; Wei RB; Li QP; Yang X; Li P; Huang MJ; Wang R; Cai GY; Chen XM
Med Sci Monit; 2015 Sep; 21():2886-92. PubMed ID: 26408630
[TBL] [Abstract][Full Text] [Related]
11. Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.
Toque HA; Priviero FB; Zemse SM; Antunes E; Teixeira CE; Webb RC
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):358-66. PubMed ID: 18986324
[TBL] [Abstract][Full Text] [Related]
12. The Association of Phosphodiesterase 5 Inhibitor on Ischemia-Reperfusion Induced Kidney Injury in Rats.
Nam JK; Kim JH; Park SW; Chung MK
Urol J; 2020 Jan; 17(1):91-96. PubMed ID: 31912478
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of tadalafil compared to sildenafil in treatment of moderate to severe canine pulmonary hypertension: a pilot study.
Jaffey JA; Leach SB; Kong LR; Wiggen KE; Bender SB; Reinero CR
J Vet Cardiol; 2019 Aug; 24():7-19. PubMed ID: 31405557
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis.
Gong B; Ma M; Xie W; Yang X; Huang Y; Sun T; Luo Y; Huang J
Int Urol Nephrol; 2017 Oct; 49(10):1731-1740. PubMed ID: 28741090
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Sildenafil and Tadalafil for Reversing Constriction of Fetal Arteries in a Human Placenta Perfusion Model.
Walton RB; Reed LC; Estrada SM; Schmiedecke SS; Villazana-Kretzer DL; Napolitano PG; Ieronimakis N
Hypertension; 2018 Jul; 72(1):167-176. PubMed ID: 29735634
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the therapeutic effects and side effects of tadalafil and sildenafil after surgery in young infants with pulmonary arterial hypertension due to systemic-to-pulmonary shunts.
Sabri MR; Bigdelian H; Hosseinzadeh M; Ahmadi A; Ghaderian M; Shoja M
Cardiol Young; 2017 Nov; 27(9):1686-1693. PubMed ID: 28994364
[TBL] [Abstract][Full Text] [Related]
17. The protective effects of tadalafil on renal damage following ischemia reperfusion injury in rats.
Erol B; Turker T; Tok A; Bektas S; Mungan G; Ozkanli S; Karakas B; Tokgoz H; Akduman B; Mungan A
Kaohsiung J Med Sci; 2015 Sep; 31(9):454-62. PubMed ID: 26362957
[TBL] [Abstract][Full Text] [Related]
18. Preventive effect of phosphodiesterase 5 inhibitor tadalafil on experimental post-pyelonephritic renal injury in rats.
Zhu CY; Liu M; Liu YZ; Li W; Zhai W; Che JP; Yan Y; Wang GC; Zheng JH
J Surg Res; 2014 Jan; 186(1):253-61. PubMed ID: 23988196
[TBL] [Abstract][Full Text] [Related]
19. Parstatin prevents renal injury following ischemia/reperfusion and radiocontrast administration.
Diamantopoulos A; Kyriazis I; Geronatsiou K; Papadaki H; Loudos G; Kagadis GC; Katsanos K; Liatsikos E; Karnabatidis D; Siamblis D; Tsopanoglou NE
Am J Nephrol; 2012; 36(3):278-86. PubMed ID: 22965158
[TBL] [Abstract][Full Text] [Related]
20. Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children.
Magee AG; Makhecha S; Bentley S
Expert Opin Drug Saf; 2015 May; 14(5):633-42. PubMed ID: 25746065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
